HIGHLIGHTS
- who: Atsushi Kawamura from the Department of Gastroenterology, Internal Medicine, Kitasato University, ‑0375, Japan have published the article: The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma, in the Journal: (JOURNAL)
- what: Patients This study was performed using previously collected data under another study that was conducted across three medical institutions in Japan from 2017 to 2020 . Some patients in this study had HBP.
- future: Evaluation of NO by direct methods will be needed for future analysis. It will be necessary to verify the influence of iNOS on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.